Philadelphia Trust Co’s Abbvie Inc Position
Does Philadelphia Trust Co own Abbvie Inc (ABBV)? Yes — 180.1K shares worth $39M (+2.76% of its 13F portfolio) as of Q1 2026, down from 182.0K shares the prior filed quarter.
Position Value
$39M
Q1 2026
Shares
180.1K
% of Portfolio
+2.76%
Quarters Held
29
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 180.1K | $39M | +2.76% |
| Q4 2025 | 182.0K | $42M | +2.87% |
| Q3 2025 | 185.7K | $43M | +3.03% |
| Q2 2025 | 193.1K | $36M | +2.75% |
| Q1 2025 | 195.7K | $41M | +3.51% |
| Q4 2024 | 210.1K | $37M | +2.74% |
| Q3 2024 | 207.8K | $41M | +2.98% |
| Q2 2024 | 207.1K | $36M | +2.76% |
| Q1 2024 | 205.7K | $37M | +3.01% |
| Q4 2023 | 193.1K | $30M | +2.81% |
| Q3 2023 | 195.4K | $29M | +2.99% |
| Q2 2023 | 205.8K | $28M | +2.62% |
| Q1 2023 | 210.3K | $34M | +3.41% |
| Q4 2022 | 226.2K | $37M | +3.91% |
| Q3 2022 | 247.5K | $33M | +3.76% |
| Q2 2022 | 221.3K | $34M | +3.48% |
| Q1 2022 | 241.3K | $39M | +3.09% |
| Q4 2021 | 254.2K | $34M | +2.49% |
| Q3 2021 | 268.1K | $29M | +2.13% |
| Q2 2021 | 271.4K | $31M | +2.11% |
| Q1 2021 | 275.2K | $30M | +2.29% |
| Q4 2020 | 276.3K | $30M | +2.41% |
| Q3 2020 | 274.3K | $24M | +2.32% |
| Q2 2020 | 228.8K | $22M | +2.37% |
| Q1 2020 | 23.3K | $2M | +0.22% |
| Q4 2019 | 92.2K | $8M | +0.70% |
| Q3 2019 | 74.1K | $6M | +0.52% |
| Q2 2019 | 16.6K | $1M | +0.11% |
| Q1 2019 | 15.7K | $1M | +0.11% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Philadelphia Trust Co’s full portfolio or all institutional holders of ABBV.